Triple
T20301452
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Alexion Pharmaceuticals |
E505487
|
entity |
| Predicate | developsTreatmentFor |
P69333
|
FINISHED |
| Object |
neuromyelitis optica spectrum disorder
Neuromyelitis optica spectrum disorder is a rare autoimmune disease in which the immune system attacks the optic nerves and spinal cord, leading to episodes of vision loss and paralysis.
|
E1423953
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: neuromyelitis optica spectrum disorder | Statement: [Alexion Pharmaceuticals, developsTreatmentFor, neuromyelitis optica spectrum disorder]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: neuromyelitis optica spectrum disorder Context triple: [Alexion Pharmaceuticals, developsTreatmentFor, neuromyelitis optica spectrum disorder]
-
A.
ADEM
ADEM is the state agency responsible for administering and enforcing environmental laws and regulations in Alabama.
-
B.
relapsing-remitting multiple sclerosis
Relapsing-remitting multiple sclerosis is the most common form of multiple sclerosis, characterized by clearly defined attacks of neurological symptoms followed by periods of partial or complete recovery.
-
C.
Guillain–Barré syndrome
Guillain–Barré syndrome is an acute autoimmune disorder in which the immune system attacks peripheral nerves, leading to rapidly progressive muscle weakness and potential paralysis, often triggered by infections such as Campylobacter.
-
D.
Neurology: Neuroimmunology & Neuroinflammation
Neurology: Neuroimmunology & Neuroinflammation is a peer-reviewed medical journal focusing on research at the intersection of the nervous and immune systems, including mechanisms and treatment of neuroinflammatory and neuroimmunologic diseases.
-
E.
progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy is a rare, often fatal demyelinating brain disease caused by reactivation of the JC virus in immunocompromised individuals, leading to rapidly progressive neurological decline.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: neuromyelitis optica spectrum disorder Triple: [Alexion Pharmaceuticals, developsTreatmentFor, neuromyelitis optica spectrum disorder]
Generated description
Neuromyelitis optica spectrum disorder is a rare autoimmune disease in which the immune system attacks the optic nerves and spinal cord, leading to episodes of vision loss and paralysis.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: neuromyelitis optica spectrum disorder Target entity description: Neuromyelitis optica spectrum disorder is a rare autoimmune disease in which the immune system attacks the optic nerves and spinal cord, leading to episodes of vision loss and paralysis.
-
A.
ADEM
ADEM is the state agency responsible for administering and enforcing environmental laws and regulations in Alabama.
-
B.
relapsing-remitting multiple sclerosis
Relapsing-remitting multiple sclerosis is the most common form of multiple sclerosis, characterized by clearly defined attacks of neurological symptoms followed by periods of partial or complete recovery.
-
C.
Guillain–Barré syndrome
Guillain–Barré syndrome is an acute autoimmune disorder in which the immune system attacks peripheral nerves, leading to rapidly progressive muscle weakness and potential paralysis, often triggered by infections such as Campylobacter.
-
D.
Neurology: Neuroimmunology & Neuroinflammation
Neurology: Neuroimmunology & Neuroinflammation is a peer-reviewed medical journal focusing on research at the intersection of the nervous and immune systems, including mechanisms and treatment of neuroinflammatory and neuroimmunologic diseases.
-
E.
progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy is a rare, often fatal demyelinating brain disease caused by reactivation of the JC virus in immunocompromised individuals, leading to rapidly progressive neurological decline.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e0b4b8ab648190906e18538c250148 |
completed | April 16, 2026, 10:06 a.m. |
| NER | Named-entity recognition | batch_69e6770c700c81909da247cef0d0f1eb |
completed | April 20, 2026, 6:57 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a08611762e481909ee2f41434c86aa5 |
completed | May 16, 2026, 12:20 p.m. |
| NEDg | Description generation | batch_6a0863506f4481909c106c49f6b71191 |
completed | May 16, 2026, 12:30 p.m. |
| NED2 | Entity disambiguation (via description) | batch_6a0863f4bb788190b6ef1fe57279badb |
completed | May 16, 2026, 12:32 p.m. |
Created at: April 16, 2026, 11:17 a.m.